Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis (CROSBI ID 312548)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Lucijanić, Marko ; Čikara, Tomislav ; Bistrović, Petra ; Papić, Ivan ; Ortner Hadžiabdić, Maja ; Busic, Nikolina ; Lackovic, Marina ; Cesar, Natalia ; Košćak, Valentina ; Mitrović, Joško ; Baršić, Bruno ; Lucijanić, Tomo
engleski
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis
Severe and critical COVID-19 patients experience high frequency of bacteremia. Bacteremia might be more frequent in remdesivir treated patients. Gram positive bacteria, especially Enterococcus faecalis are of special concern. Occurrence of bacteremia moderates association of remdesivir use with survival.
Remdesivir ; bacteriaemia ; covid-19
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
85 (2)
2022.
174-211
objavljeno
0163-4453
1532-2742
10.1016/j.jinf.2022.04.045
Povezanost rada
Javno zdravstvo i zdravstvena zaštita
